4Tsouko E, Wang J, Frigo DE, et al. miR -200a inhibits migration of triple - negative breast cancer cells through direct repression of theEP-HA2 oncogene [ J ]. Carcinogenesis, 2015,36 ( 9 ) : 1051 - 1060.
5Yao N, Ren K, Jiang C, et al. Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo[ J]. Tumour Biol, 2015,36( 11 ) :8499 -8510.
6Lohmtiller T, Xu Q, Groves JT. Nanoscale obstacle arrays frustrate transport of EphA2 -Ephrin -A1 clusters in cancer cell lines[ Jl. Nano Lett, 2013,13(7) :3059 -3064.
7Interiano RB, Yang J, Harris AL, et al. Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF - 7 breast cancer cells [J]. J Surg Res, 2014,190 ( 1 ) :203 - 209.
8Elgazzar S, Zembutsu H, Takahashi A, et al. A genome - wide associa- tion study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor - positive breast cancer in Japanese [J].J Hum Gen- et, 2012,57(12) :766 -771.
9Sarkar TR, Sharan S, Wang J, et al. Identification of a Src tyrosine ki- nase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBP8 expres- sion and contributes to transformation of breast tumor cells[ J]. Mol Cell Biol, 2012,32(2) :320 -332.
10Yasuhara R, Iri6 T, Suzuki K, et al. The 13 - catenin signaling pathway induces aggressive potential in breast cancer by up - regulating the ehe- mokine CCL5 [ J]. Exp Cell Res, 2015,338 ( 1 ) :22 - 31.
